# Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects

> **NCT06622148** · PHASE1 · COMPLETED · sponsor: **Sichuan Huiyu Pharmaceutical Co., Ltd** · enrollment: 48 (actual)

## Conditions studied

- Bioequivalency
- Safety Issues

## Interventions

- **DRUG:** Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer)
- **DRUG:** Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd)

## Key facts

- **NCT ID:** NCT06622148
- **Lead sponsor:** Sichuan Huiyu Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-25
- **Primary completion:** 2024-07-26
- **Final completion:** 2024-07-26
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06622148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06622148, "Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06622148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*